Peer-reviewed journal articles (257)
131.
Darro, F., Decaestecker, C., Gaussin, J.-F., Mortier, S., Van Ginckel, R., & Kiss, R. (2005). Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery? International journal of oncology, 27(3), 607-616.132.
Camby, I., Decaestecker, C., Lefranc, F., Kaltner, H., Gabius, H.-J., & Kiss, R. (2005). Galectin-1 knocking down in human U87 glioblastoma cells alters their gene expression pattern. Biochemical and biophysical research communications, 335(1), 27-35. doi:10.1016/j.bbrc.2005.07.037133.
Mathieu, A., Saal, I., Vuckovic, A., Ransy, V., Vereerstraeten, P., Kaltner, H., Gabius, H.-J., Kiss, R., Decaestecker, C., Salmon, I., & Remmelink, M. (2005). Nuclear galectin-3 expression is an independent predictive factor of recurrence for adenocarcinoma and squamous cell carcinoma of the lung. Modern pathology, 18(9), 1264-1271. doi:10.1038/modpathol.3800416135.
Lefranc, F., Mijatovic, T., Decaestecker, C., Kaltner, H., André, S., Brotchi, J., Salmon, I., Gabius, H.-J., & Kiss, R. (2005). Monitoring the expression profiles of integrins and adhesion/growth-regulatory galectins in adamantinomatous craniopharyngiomas: their ability to regulate tumor adhesiveness to surrounding tissue and their contribution to prognosis. Neurosurgery, 56(4), 763-776.136.
Van Quaquebeke, E., Simon, G., André, A., Dewelle, J., El Yazidi, M., Bruyneel, F., Tuti, J., Nacoulma, O., Guissou, P., Decaestecker, C., Braekman, J. C., Kiss, R., & Darro, F. (2005). Identification of a novel cardenolide (2''-oxovoruscharin) from Calotropis procera and the hemisynthesis of novel derivatives displaying potent in vitro antitumor activities and high in vivo tolerance: structure-activity relationship analyses. Journal of medicinal chemistry, 48(3), 849-856. doi:10.1021/jm049405a137.
Remmelink, M., Mijatovic, T., Gustin, A., Mathieu, A., Rombaut, K., Kiss, R., Salmon, I., & Decaestecker, C. (2005). Identification by means of cDNA microarray analyses of gene expression modifications in squamous non-small cell lung cancers as compared to normal bronchial epithelial tissue. International journal of oncology, 26(1), 247-258.138.
D'Haene, N., Maris, C., Sandras, F., Dehou, M. F., Remmelink, M., Decaestecker, C., & Salmon, I. (2005). The differential expression of Galectin-1 and Galectin-3 in normal lymphoid tissue and non-Hodgkin's and Hodgkin's lymphomas. International journal of immunopathology and pharmacology, 18(3), 431-443.139.
Lefranc, F., Mijatovic, T., Mathieu, V., Rorive, S., Decaestecker, C., Debeir, O., Brotchi, J., Van Ham, P., Salmon, I., & Kiss, R. (2004). Characterization of gastrin-induced proangiogenic effects in vivo in orthotopic U373 experimental human glioblastomas and in vitro in human umbilical vein endothelial cells. Clinical cancer research, 10(24), 8250-8265. doi:10.1158/1078-0432.CCR-04-0343140.
Hancq, S., Salmon, I., Brotchi, J., Gabius, H.-J., Heizmann, C. W., Kiss, R., & Decaestecker, C. (2004). Detection of S100B, S100A6 and galectin-3 ligands in meningiomas as markers of aggressiveness. International journal of oncology, 25(5), 1233-1240.141.
Legendre, H., Decaestecker, C., Goris Gbenou, M., Nagy, N., Hendlisz, A., André, S., Pector, J. C., Kiss, R., & Gabius, H.-J. (2004). Prognostic stratification of Dukes B colon cancer by a neoglycoprotein. International journal of oncology, 25(2), 269-276.142.
Gaigneaux, A., Decaestecker, C., Camby, I., Mijatovic, T., Kiss, R., Ruysschaert, J. M., & Goormaghtigh, E. (2004). The infrared spectrum of human glioma cells is related to their in vitro and in vivo behavior. Experimental cell research, 297(1), 294-301. doi:10.1016/j.yexcr.2004.03.031